Texas Children's Cancer Center

Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.

The new Pediatric Center for Personal Cancer Genomics and Therapeutics plans to routinely sequence every new patient that comes into the Texas Children's Cancer Center and hopes eventually to begin sequencing all new pediatric cancer cases in the state of Texas.

BCM has started a new pediatric cancer research center that will use clinical tumor sequencing for research and to develop treatments.

The Doris Duke Charitable Foundation has given a nearly $500,000 grant to the Texas Children's Cancer Center and Baylor to identify glioma-causing genetic mutations.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.